4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > juhewu > axonmedchem/ABT 199-GDC 0199 | Venetoclax/5毫克/Axon 2141
商品详细axonmedchem/ABT 199-GDC 0199 | Venetoclax/5毫克/Axon 2141
axonmedchem/ABT 199-GDC 0199 | Venetoclax/5毫克/Axon 2141
axonmedchem/ABT 199-GDC 0199 | Venetoclax/5毫克/Axon 2141
商品编号: Axon2141
品牌: axon medch
市场价: ¥1800.00
美元价: 900.00
产地: 美国(厂家直采)
公司:
产品分类: 聚合物
公司分类: juhewu
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

ABT 199 - GDC 0199 | Venetoclax

Based on 16 reference(s) in Google Scholar91016

Axon 2141

CAS [1257044-40-8]

MF C45H50ClN7O7SMW 868.44

  • Purity:98%
  • Soluble in DMSO

ABT 199

Description

A highly potent, orally bioavailable BCL-2-selective inhibitor; a new Bcl-2–specific BH3 mimetic efficacious in vivo against mouse lymphomas without provoking thrombocytopenia.

KEYWORDS: ABT 199 | supplier | Bcl-2 inhibitor | GDC 0199 | Venetoclax | ABT199 | GDC0199 | ABT-199 | GDC-0199 | CAS [1257044-40-8] | Non Selective | Bcl | Inhibitor | Proteins

AJ Souers et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 2013, 19(2), 202-208.
C Touzeau et al. The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma. Leukemia advance online publication 16 August 2013;doi: 10.1038/leu.2013.216.
CJ Vandenberg and S Cory. ABT-199, a new Bcl-2–specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. Blood, 2013, 121(12), 2285-2288.
  • Certificate of Analysis
  • Material Safety Data Sheet
ApoptosisCell Cycle RegulationCell Signaling & OncologyBcl
Potent, orally bioavailable BCL-2-selective inhibitor

Chemical name

2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(3-nitro-4-((tetrahydro-2H-pyran-4-yl)methylamino)phenylsulfonyl)benzamide

Parent CAS No.

[1257044-40-8]

品牌介绍
荷兰Axon Medchem BV公司从Axon Biochemicals BV剥离出来,是欧洲**的化学服务平台,专业从事合同研究和高品质的生物活性和/或药物类似分子的合成。Axon Medchem连同Axon Biochemicals公司作为医药化学领域的合同研究组织(CRO)进行商业运作。 Axon Medchem也是高价值的生命科学产品的主要来源,提供药品研究用的Axon Ligands (TM)系列。